Лекарство от онкологии уже в вашем теле — исследование ученых, которое поможет победить рак поджелудочной
Лекарство от онкологии уже в вашем теле — исследование ученых, которое поможет победить рак поджелудочной ФОНТАНКА.ру
Лекарство от онкологии уже в вашем теле — исследование ученых, которое поможет победить рак поджелудочной ФОНТАНКА.ру
Дараксонрасиб превзошёл химиотерапию при раке поджелудочной железы — News-Medical UA.NEWS
KRAS-targeting vaccine prompts immune responses in pancreatic cancer patients News-Medical
Digital tools and phone coaching boost cancer genetic testing uptake News-Medical
Targeted drug extends survival across diverse pancreatic cancer patient groups News-Medical
Исследователи KIT определили CD44 как мишень при раке поджелудочной железы — News-Medical UA.NEWS
Врачи центра Блохина спасли 83-летнюю женщину от рака перед ее свадьбой The World Inform
Scientists discovered that the thick, sticky fluid surrounding glioblastoma tumors can make brain cancer cells smaller, more flexible, and better at invading surrounding tissue. Even more troubling, some of these changes persist after the cells leave the thick fluid, revealing a previously overlooked mechanism that…
Prostate cancer is the most common cancer in men—in 2013, it affected more than 1 million men across the world. The cancer does not behave the same way in every patient, and doctors have long faced a difficult balancing act between identifying patients who will benefit from more intensive treatment and those who may…
At the Register, Small Gifts Add Up for Breast Cancer Patients Sutter Health
Pancreatic cancer is one of the most aggressive and difficult-to-treat cancers. One reason for its resistance to therapy is the dense tissue surrounding the tumor that acts as a protective barrier and suppresses the immune response. It is a complex tissue made of supporting cells, blood vessels and immune cells—the…
Sacituzumab Govitecan Triplet Elicits Durable Responses in Treatment-Naive Metastatic Urothelial Cancer OncLive
Merck and Moderna release promising data on cancer vaccine trial NPR
New research indicates that commonly used measures of kidney function underestimate the prevalence of chronic kidney disease (CKD) in patients with cancer. The findings will be presented at ASN Kidney Week 2026, Oct. 22–25.
Celebrating 8 Community Members Elected to the National Academy of Medicine - The Mark Foundation for Cancer Research Oncodaily